PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $413,000 | +103.4% | 55,300 | +61.7% | 0.01% | +150.0% |
| Q4 2017 | $203,000 | -25.4% | 34,200 | -7.3% | 0.00% | -33.3% |
| Q3 2017 | $272,000 | -11.1% | 36,900 | -18.2% | 0.00% | -25.0% |
| Q2 2017 | $306,000 | +18.1% | 45,100 | +64.6% | 0.00% | +33.3% |
| Q1 2017 | $259,000 | +488.6% | 27,400 | +163.5% | 0.00% | +200.0% |
| Q2 2016 | $44,000 | -84.9% | 10,400 | -78.2% | 0.00% | -75.0% |
| Q4 2015 | $292,000 | +87.2% | 47,600 | +74.4% | 0.00% | +100.0% |
| Q3 2015 | $156,000 | – | 27,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Phocas Financial Corp. | 1,033,328 | $6,376,000 | 0.68% |
| ARDSLEY ADVISORY PARTNERS LP | 650,000 | $4,011,000 | 0.63% |
| Worth Venture Partners, LLC | 138,357 | $853,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,242,503 | $13,836,000 | 0.46% |
| HIGHLAND CAPITAL MANAGEMENT LP | 716,880 | $4,423,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,543,386 | $34,203,000 | 0.22% |
| Point72 Asset Management, L.P. | 5,858,749 | $36,148,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 1,298,723 | $8,013,000 | 0.19% |
| Fosun International Ltd | 472,580 | $2,750,000 | 0.18% |
| J. Goldman & Co LP | 400,000 | $2,468,000 | 0.17% |